Johnson & Johnson Enters Final Stages of Vaccine Testing
The race for a vaccine for COVID-19 has been on since the virus began wreaking havoc on our nation, and it looks as if Johnson & Johnson is in the final stages of preparing a vaccine.
Multiple companies have been working on a vaccine and having trials that began this summer. However, J&J is the first to come up with a single dose vaccine, one that would only require one shot instead of two. Phase 3 of J&J’s testing will include 60,000 participants, and there is hope for results by the end of this year.
Johnson & Johnson’s Covid-19 vaccine candidate begins Phase 3 trials in the US today on up to 60,000 adult participants.
Moderna, Pfizer/BioNTech and AstraZeneca also have Covid-19 vaccine candidates in Phase 3 trials in the US tho AstraZeneca’s trial is currently paused.
— Jake Tapper (@jaketapper) September 23, 2020
News of the final stages comes after conflicting comments from President Trump. Back in August, the President was confidently sharing that the vaccine would be ready before Election Day, something that Dr. Anthony Fauci has denied. Just days ago, Trump came under fire for saying that COVID-19 “virtually affects nobody” at a rally in Ohio. These comments spark confusion among the American people just as the death toll reaches 200,000 in the U.S. Nevertheless, Trump continues to boast progress on the development of a vaccine.
White House News Conference today at 6:00 P.M. Economy, Job gains and Vaccine development are all doing GREAT!
— Donald J. Trump (@realDonaldTrump) September 23, 2020
The same Johnson & Johnson that sold talcum powder that causes cancer!? 😳✋ https://t.co/sxev0xPSXM
— Mabel Carolina Perez (@vivalebam) September 23, 2020